Phibro (PAHC) Insider Grant: 3,447 RSUs to General Counsel

Rhea-AI Filing Summary

Judith Weinstein, Senior Vice President, General Counsel and Corporate Secretary of Phibro Animal Health Corp (PAHC), was granted 3,447 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to receive one share of Class A common stock and the reported ownership following the grant is 3,447 shares (direct). The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date. The Form 4 was signed and dated 08/19/2025.

Positive

• 3,447 RSUs granted to a named officer, clearly disclosed
• Vesting schedule specified: substantially equal installments on each of the first three anniversaries of 08/01/2025
• Direct beneficial ownership after grant explicitly reported as 3,447 shares

Negative

• None.

Insights

Securities Analyst

Routine equity grant to an officer; limited near-term market impact.

The filing documents a standard equity compensation award of 3,447 RSUs to the company's Senior Vice President and General Counsel. The award vests over three annual installments beginning August 1, 2025, and is recorded as a direct beneficial ownership of 3,447 shares following the grant. There are no sales, option exercises, or cash proceeds reported. From a market perspective, this transaction is a routine internal compensation action and does not by itself signal changes to corporate strategy, capital structure, or liquidity.

Corporate Governance Expert

Compensation disclosure consistent with standard governance and disclosure practices.

The Form 4 correctly discloses an RSU grant to an officer and specifies vesting mechanics: substantially equal installments on each of the first three anniversaries of the specified vesting commencement date. The disclosure identifies the reporting person and her role. The submission appears complete for a Section 16 insider grant and provides the required details for investor transparency regarding insider holdings and potential future dilution as RSUs convert to shares upon vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weinstein Judith

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/15/2025		A		3,447(2)	A	$0	3,447	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Remarks:

Senior Vice President, General Counsel and Corporate Secretary.

	/s/ Judith Weinstein	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Judith Weinstein report on Form 4 for PAHC?

The Form 4 reports a grant of 3,447 restricted stock units (RSUs) to Judith Weinstein, Senior Vice President, General Counsel and Corporate Secretary.

When was the transaction date and when was the Form 4 signed?

The transaction date is 08/15/2025 and the Form 4 was signed on 08/19/2025.

What is the vesting schedule for the RSUs?

The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date.

How many shares does Weinstein beneficially own following the grant?

The filing reports 3,447 shares beneficially owned following the reported transaction, held directly.

What type of security was reported on the Form 4?

The reported securities are Class A Common Stock RSUs, each representing a contingent right to one share of Class A common stock.